Laurent Elkrief
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
The Montreal model of ketamine-therapy for alcohol use disorder and comorbid treatment-resistant depression: protocol for a feasibility trial.
Journal: BMJ open
Published: March 20, 2026
NEUROMODULATION IN PSYCHOGERIATRICS: EMERGING EVIDENCE AND FUTURE DIRECTIONS.
Journal: Psychiatria Danubina
Published: September 22, 2025
Beyond Lectures: Reimagining Psychiatric Didactics for the Age of AI.
Journal: JMIR medical education
Published: June 02, 2025
Stepwise interventional psychiatry approach for major depression: A case series.
Journal: Journal of psychiatric research
Published: May 29, 2025
Is Naltrexone Effective and Safe for Treating Amphetamine-Type Stimulant Use Disorder? A Systematic Review and Meta-analysis.
Journal: Journal of addiction medicine
Published: November 26, 2024
Efficacy and Safety of Modafinil for Treatment of Amphetamine-Type Stimulant Use Disorder: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials: Efficacité et innocuité du modafinil pour le traitement des troubles liés à l'usage de stimulants de type amphétamine : revue systématique et méta-analyse d'essais randomisés contrôlés par placebo.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie
Published: July 21, 2024
Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial.
Journal: Journal of dual diagnosis
Published: April 05, 2024
State of the Science: The Hierarchical Taxonomy of Psychopathology (HiTOP).
Journal: Behavior therapy
Published: January 26, 2024
Independent contribution of polygenic risk for schizophrenia and cannabis use in predicting psychotic-like experiences in young adulthood: testing gene × environment moderation and mediation.
Journal: Psychological medicine
Published: June 13, 2023
Intravenous ketamine for treatment-resistant depression patients who have failed to respond to transcranial magnetic stimulation: A case series.
Journal: Journal of affective disorders
Published: November 08, 2022
Differential effect of cannabis use on opioid agonist treatment outcomes: Exploratory analyses from the OPTIMA study.
Journal: Journal of substance use and addiction treatment
Published: August 24, 2022
Transcranial magnetic stimulation and intravenous ketamine combination therapy for treatment-resistant bipolar depression: A case report.
Journal: Frontiers in psychiatry
Published: July 05, 2022
Last Updated: 09/26/2026